Latest Headlines

  1. Lupin To Build New Drug Manufacturing Facility In Coral Springs, Florida 10/10/2025

    Global pharmaceutical leader, Lupin, today announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral Springs, a significant step in safeguarding the health and safety of Florida families and the nation.

  2. Groninger Invests In The Future: Building A state-Of-The-Art Assembly Hall At Its Crailsheim Headquarters 10/8/2025

    groninger is expanding: A new assembly hall and adjoining office complex are being built, covering more than 75,000 square feet. With an investment volume of over 30 million euros, it marks the largest single investment in the company’s history.

  3. TORL Biotherapeutics Secures $96M For ADC Drug Development From UCLA Lab 10/7/2025

    TORL BioTherapeutics LLC (TORL), a clinical stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide, today announced closing of a $96 million Series C financing. Additionally, updated results from the ongoing Phase 1 study of the Company's Claudin 6 (CLDN6) targeted antibody-drug conjugate (ADC) TORL-1-23 in patients with advanced cancer will be presented in poster sessions at the 2025 European Society of Medical Oncology Congress (ESMO 2025) in Berlin, Germany.

  4. FDA Announces New ANDA Prioritization Pilot To Support U.S. Generic Drug Manufacturing And Testing 10/6/2025

    Today, the U.S. Food and Drug Administration (FDA) is announcing a new pilot prioritization program for the review of abbreviated new drug applications (ANDAs) that aims to spur and reward investment in U.S. drug manufacturing and research and development and strengthen the domestic pharmaceutical supply chain by providing faster reviews for generic companies who test and manufacture their products in the U.S.

  5. groninger At CPHI 2025: Efficient, Flexible, Scalable 10/6/2025

    From October 28 to 30, 2025, the international pharmaceutical industry will gather in Frankfurt for CPHI – one of the most important global events in the sector. Among the exhibitors: groninger, a specialist in filling and closing systems, showcasing innovative machine solutions for processing pharmaceutical liquids in small and medium batch sizes. On the 130-square-meter exhibition space, visitors will experience firsthand how groninger responds to current industry demands with flexible and scalable machine concepts.

  6. Eli Lilly To Invest $1B+ In India To Expand Global Drug Manufacturing And Supply 10/6/2025

    Eli Lilly (LLY.N) will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion.

  7. OPTIMA Machinery Ireland Ltd. Officially Founded 10/2/2025

    The Optima Group has founded a new company, OPTIMA machinery Ireland Ltd. With this new location, Optima is expanding its international presence and strengthening its activities in Ireland.

  8. CDMO AbbVie Begins Construction On Biologics Manufacturing Facility Expansion In Massachusetts 10/2/2025

    AbbVie today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.

  9. Federal Equipment Company Announces Exclusive Sale Of Brand-New Aseptic Processing & Sterilization Equipment 10/2/2025

    Federal Equipment Company is pleased to announce the exclusive consignment of a suite of brand-new, never-used equipment designed for pharmaceutical and biotech aseptic processing. These state-of-the-art systems from leading manufacturers are now available for immediate purchase, offering buyers a unique opportunity to acquire high-performance technologies without the typical lead times of new builds.

  10. Precision Biologics Manufacturing Expands U.S. Production with Nevada Groundbreaking 10/1/2025

    Precision Biologics Manufacturing, a New Horizon Medical Solutions (NHMS) company, announced a groundbreaking for its manufacturing facility, to develop advanced biologics technology and to bring MedTech jobs to Southern Nevada. Operated by Precision Biologics Manufacturing, the center will expand U.S.-based biologics production and create more than 200 to 300 healthcare-centric jobs in the Las Vegas Valley beginning in the second half of 2026.